Mesoblast Statistics
NASDAQ: MESOHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
10.89-0.29 (-2.59%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Mesoblast by the numbers
Mesoblast has a market capitalization of $1.41 billion based on 129.85M shares outstanding. With trailing EPS of $-0.44, Mesoblast is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 21.4% below its 50-day average and 27.8% below its 200-day average.
Average daily trading volume is 240.68K shares, or about $2.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
MESO valuation vs. peer median
| Metric | MESO | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.41B | $1.41B | +1% |
| Avg. volume | 240.68K | 1.79M | -87% |
Peer median across 8 companies: WWB, IMCR, ALVO, RXRX, VIR, NVAX, TSHA, VOR.
Valuation
- Market cap
- $1.41B
- Forward P/E
- 31.11
- Price / sales (latest FY)
- 82.23
- EPS (TTM)
- $-0.44
- Shares outstanding
- 129.85M
Price and trading
- Previous close
- 11.18
- Open
- 11.11
- Day range
- 10.87 – 11.44
- 52-week range
- 10.87 – 21.50
- 52-week change
- -29.15%
- Beta
- —
- Volume
- 192.70K
- Average volume
- 240.68K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 26, 2026
Additional statistics
- Market Cap
- 1.41B
- Forward Pe
- 31.11
- Eps
- -0.44
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 21.50
- Week52 Low
- 10.87
- Avg Volume
- 240.68K
- Shares Outstanding
- 129.85M
- Ma50
- 13.86
- Ma200
- 15.07
- Earnings Date
- Aug 26, 2026
- Pct From52w High
- -49.35%
- Pct From52w Low
- 0.18%